Показать сокращенную информацию
dc.contributor.author | Kozlov M. | |
dc.contributor.author | Kleymenova A. | |
dc.contributor.author | Konduktorov K. | |
dc.contributor.author | Malikova A. | |
dc.contributor.author | Kochetkov S. | |
dc.date.accessioned | 2018-09-18T20:02:08Z | |
dc.date.available | 2018-09-18T20:02:08Z | |
dc.date.issued | 2014 | |
dc.identifier.issn | 0006-2979 | |
dc.identifier.uri | https://dspace.kpfu.ru/xmlui/handle/net/135932 | |
dc.description.abstract | Acetylation of α-tubulin was studied in cultures of human hepatocytes under the influence of selective inhibitors of histone deacetylases HDAC6 and SIRT-2 - tubastatin A and 2-(3-phenethoxyphenylamino)benzamide, respectively. It was found that in hepatocyte cell line HepG2 acetylated α-tubulin is accumulated preferentially on inhibition of HDAC6 but not of SIRT-2. Under the same conditions, no acetylation of α-tubulin was observed in hepatocyte cell line Huh7. However, the inhibition of HDAC6 with tubastatin A led to hyperacetylation of α-tubulin and simultaneously to decrease in viral RNA concentration in hepatocyte cell line Huh7-luc/neo, which supports propagation of the full genome replicon of hepatitis C virus. The correlation between these two processes points to HDAC6 as a promising cellular target for therapy of hepatitis C. © 2014 Pleiades Publishing, Ltd. | |
dc.relation.ispartofseries | Biochemistry (Moscow) | |
dc.subject | acetylation of α-tubulin | |
dc.subject | HDAC6 and SIRT-2 | |
dc.subject | hepatitis C virus replicon | |
dc.subject | human hepatocytes | |
dc.title | Selective inhibitor of histone deacetylase 6 (tubastatin A) suppresses proliferation of hepatitis C virus replicon in culture of human hepatocytes | |
dc.type | Article | |
dc.relation.ispartofseries-issue | 7 | |
dc.relation.ispartofseries-volume | 79 | |
dc.collection | Публикации сотрудников КФУ | |
dc.relation.startpage | 637 | |
dc.source.id | SCOPUS00062979-2014-79-7-SID84906228124 |